baber/WOPTO huggingface dataset:
Patent CA-2615247-A1 (CA)
Title: System, method, and apparatus for automated interactive verification of an alert generated by a patient monitoring device
Inventor: COSENTINO LOUIS C
IPC: G06F19/00
Filed: 2006-07-12
Abstract: A system for verification of an alert generated by an assessment process operating upon patient feedback and physiological data. The system may utilize a categorization for alerts, in order to obtain a rule set corresponding thereto. A question hierarchy may correspond to each rule within the rule set.  Each question hierarchy may be posed to the patient to verify the alarm. The verification process may be carried out by a patient monitoring apparatus. The system may also automatically adjust parameter thresholds, and may automatically assess the effectiveness of individual questions in predicting the onset of health care related events.
Patent CA-2616957-A1 (CA)
Title: Antitumoral bioconjugates of hyaluronic acid or its derivatives obtained by indirect chemical conjugation
Inventor: RENIER DAVIDE
IPC: A61K47/48
Filed: 2006-08-02
Abstract: The present invention describes a new group of bioconjugates which can be obtained by means of indirect synthesis, via a molecular spacer, between hyaluronic acid and/or its derivatives and drugs with an antitumoral activity belonging to different groups, their preparation process and use in the oncological field. The new derivatives, in relation to the type of bond and Substitution degree, have different physico-chemical properties which improve their tolerability and efficiency and allow a more accurate modulation of the dosage, exploiting an active targeting mechanism.
Patent CA-2619244-A1 (CA)
Title: Engineered antibodies with new world primate framework regions
Inventor: JENNINGS PHILIP ANTHONY
IPC: A61K39/395
Filed: 2006-08-15
Abstract: The present invention provides an antibody or antigen-binding portion thereof having a variable region comprising at least two complementarity determining regions (CDRs) and at least three framework regions. The the framework regions are, or are derived from New World primate framework regions, and at least one of the CDRs is a non-New World primate CDR.
Patent CA-2619675-A1 (CA)
Title: Thermally primed hydrogen-producing fuel cell system
Inventor: EDLUND DAVID J
IPC: H01M8/04
Filed: 2006-08-23
Abstract: Thermally primed fuel processing assemblies and hydrogen-producing fuel cell systems that include the same. The thermally primed fuel processing assemblies include at least one hydrogen-producing region housed within an internal compartment of a heated containment structure. In some embodiments, the heated containment structure is an oven. In some embodiments, the compartment also contains a purification region and/or heating assembly.  In some embodiments, the containment structure is adapted to heat and maintain the internal compartment at or above a threshold temperature, which may correspond to a suitable hydrogen-producing temperature. In some embodiments, the containment structure is adapted to maintain this temperature during periods in which the fuel cell system is not producing power and/or not producing power to satisfy an applied load to the system. In some embodiments, the fuel cell system is adapted to provide backup power to a power source, which may be adapted to power the containment structure.
Patent CA-2621442-A1 (CA)
Inventor: MOOTE STANLEY ROBERT
IPC: H04L12/00
Filed: 2008-02-15
Abstract: A routing switcher performs various soft signaling processing within the router using one or more internal soft media processors (central processing units) to enable flexible solutions. The routing switcher includes a plurality of inputs and outputs operably connected by a cross-point matrix where the inputs are dynamically coupled to one or more of the outputs. The routing switcher also includes a soft media processor connected to the cross-point matrix as well as being dynamically coupled between some inputs and outputs. The soft media processor receives a signal from an input via the cross-point matrix and performs one of at least two signaling processing functions resident on the soft media processor and outputs a processed signal from one or more of the routing switcher's outputs.
Patent CA-2622461-A1 (CA)
Inventor: SHINGLER WILLIAM
IPC: A61K45/06
Filed: 2006-09-21
Abstract: A method of treating or preventing a disease, said method comprising administering to a subject, simultaneously, sequentially or separately, an antigen and a chemotherapeutic agent or agents comprising the steps of:  administering the chemotherapeutic agent or agents, and administering an antigen up to 6 weeks after the chemotherapeutic agent.
Patent CA-2622614-A1 (CA)
Inventor: HU HUAPING
IPC: A61K31/519
Filed: 2006-09-13
Abstract: The invention addresses the current need for selective and potent protein tyrosine kinase inhibitors by providing potent inhibitors of c-fms kinase. The invention is directed to the novel compounds of Formula I: or a solvate, hydrate, tautomer or pharmaceutically acceptable salt thereof, wherein:W, A, Y, n, Z, and R102 are described in the specification.
Patent CA-2624198-A1 (CA)
Inventor: GELFMAN DANIEL M
IPC: A62B23/06
Filed: 2006-09-21
Abstract: A nasal air filtration device includes a pair of either planar or concave-convex filters, a support structure incorporating a pair of generally annular bases or sleeves for supporting the filters, and a bridge that couples the bases or sleeves to maintain them in a desired spaced-apart relation and to determine a desired angular relationship. The support structure is insertable into the nasal cavities to position the filters within corresponding nasal cavities. Flexible rims maintain the support structure and the filters in spaced-apart relation to the surrounding nasal wall. The rims conform to surrounding nasal tissue to form seals. The rims can be selectively inclined to facilitate insertion and resist accidental removal. In certain embodiments the device is combined with a filter that covers the mouth to provide an air filtration system.
Patent CA-2624777-A1 (CA)
Inventor: KELLY HUGH-PETER GRANVILLE
IPC: F03B13/16
Filed: 2006-10-10
Abstract: A float for use in capturing energy from waves, said float comprising: a central body providing buoyancy, said float further comprising: a leading part which has a leading surface which, in use of the float, is inclined upwards from horizontal such that the top of said leading surface projects further from said central body than the bottom of said leading surface and/or a trailing part which, in use of said float, extends downwards from said central body and presents a trailing surface which is inclined downwards from horizontal such that the top of said trailing surface is closer to said body than the bottom of said trailing surface.
Patent CA-2627661-A1 (CA)
Inventor: WEEBER HENK A
IPC: A61F2/16
Filed: 2006-10-23
Abstract: A haptic (30, 50, 59, 69, 89) is provided for use in an accommodating intraocular lens. The haptic has multiple filaments, each connected to the edge of the optic (28,48,58,68,88,98,108) at one end. Each filament has a shape that conforms to an equatorial region of the capsular bag (18). The haptic couples the forces exerted by the capsular bag of the eye (10) during accommodation radially to the edge of the optic, produce a diametric expansion or compression of the optic. This diametric motion distorts the optic, producing a change in any or all of the anterior radius, the posterior radius, and the thickness. These changes affect the power of the lens and/or location of the image. The haptic may optionally have a thin membrane (66) joining the filaments at the optic end, and may optionally have a connecting ring (62) that joins the filaments at the end opposite that of the optic.
Patent CA-2628506-A1 (CA)
Title: Combinations of metformin and meglitinide
Inventor: GEESAMAN BARD J
IPC: A61K31/155
Filed: 2006-11-07
Abstract: Methods of treating glucose related disorders, for example by administering a meglitinide such as mitiglinide, repaglinide, or nateglinide, optionally in combination with a biguanide such as metformin, are described herein.
Patent CA-2629681-A1 (CA)
Title: Multiple generator loadcenter and method of distributing power from multiple generators
Inventor: LATHROP TODD M
IPC: H02J3/06
Filed: 2008-04-23
Abstract: A loadcenter supplies power to a non-critical load, a critical load and an ultra-critical load, and is capable of isolating a first distribution panel distributing power to the non-critical load from a second distribution panel distributing power to the critical load to enable the isolated distribution panels to be supplied with power from separate generator power sources in response to power supplied by a utility power source to both distribution panels becoming unacceptable. A third distribution panel distributes power to the ultra-critical load and is selectively supplied with alternating current (AC) power from either the second distribution panel, when the second distribution panel has AC power, or from AC power generated from direct current (DC) power stored in a battery when the second distribution panel lacks AC  power.
Patent CA-2630815-A1 (CA)
Inventor: CRNKOVICH ANDREW
IPC: F24C15/08
Filed: 2006-12-01
Abstract: A gas cook-top with glass (capacitive) touch controls and automatic burner re-ignition is provided. The gas cook-top utilizes a variable flow gas control valve that is driven by an electronic controller whose user interface provides a glass capacitive touch interface. Various electronic features including safety lockouts and burner re-ignition are provided, as is relational control of the burner flame. As a user moves their finger along a flame adjust indicator, the electronic control positions the variable flow gas valve to control the flame height of the burner to correspond to the relative position along the indicator selected by the user.
Patent CA-2631488-A1 (CA)
Inventor: SCHWARTZ YITZHACK
IPC: G01D5/20
Filed: 2008-05-16
Abstract: The problem of accessing an injection port transcutaneously is resolved using wireless position transducers in an inflation port assembly and in an injection syringe. The measurements provided by the transducers indicate to the practitioner the position and orientation of syringe relative to the injection port. A console provides a visual indication of the relative position and orientation so as to guide the practitioner to insert the syringe at the proper site and in the proper direction and to penetrate the port cleanly and correctly.
Patent CA-2631877-A1 (CA)
Inventor: ANGLES D AURIAC MARC
IPC: C12N5/00
Filed: 2006-12-12
Abstract: The present invention relates to a method for detecting the presence or absence of a target cell in a sample, said method comprising (a) binding cells in said sample to a particulate and mixable solid support; (b) eluting the cells from the solid support without the use of competitor molecules to disrupt the interaction between the cell and the solid support; (c) after lysis of said cells, detecting the presence or absence of nucleic acid characteristic of said target cell, wherein said solid support does not have antibodies or antibody fragments immobilised thereon. Kits for carrying out the method of the invention are also provided.
Patent CA-2633438-A1 (CA)
Title: Combustion catalyst carriers and methods of using the same
Inventor: THOMPSON MICHAEL D
IPC: C10L1/30
Filed: 2006-11-17
Abstract: Compositions including a fuel soluble ferrocene compound and a fuel soluble solid carrier are disclosed. Methods of preparing tablet forms of the compositions are also disclosed. The fuel soluble ferrocene compound may be ferrocene and/or ferrocene derivatives. The compositions are useful for handling and rapidly solvating the fuel soluble ferrocene compound in a fuel such as gasoline.
Patent CA-2633882-A1 (CA)
Title: Method and systems using radio frequency identifier tags for comparing and authenticating items
Inventor: BAUCHOT FREDERIC
IPC: G06F21/44
Filed: 2006-10-16
Abstract: A method and system for identifying an authentication status of a first item. An RFID reader transmits zero and a random number to a first RFID tag associated with the first item. The first RFID tag uses a hashing function to compute a hash (H1) of a concatenation of an identifier (Id1) of the first RFID tag, the random number, and a first secret key and sends the hash H1 to the RFID reader which then transmits the identifier Id1 and the random number to a second RFID tag. The second RFID tag uses the hashing function to compute a hash (H2) of a concatenation of the identifier Id1, the random number, and a second secret key and sends the hash H2 to the RFID reader. The authentication status of authentic or counterfeit is determined for the first item based on whether or not H1 is equal to H2.
Patent CA-2634006-A1 (CA)
Title: Pharmaceutical sustained release compositions comprising liothyronine or the sodium salt of liothyronine
Inventor: SMITH ALAN
IPC: A61K31/195
Filed: 2006-12-15
Abstract: There is provided sustained release pharmaceutical compositions comprising a drug; microcrystalline cellulose; a diluent (such as starch); a glidant (such as talc); and one or more of ethylcellulose, stearic acid and a salt of stearic acid. Preferred drugs include those that exhibit a low degree of solubility combined with a high potency, particularly thyroid hormones, such as liothyronine.
Patent CA-2637459-A1 (CA)
Inventor: STUTZ STEFAN
IPC: C07D413/12
Filed: 2007-01-18
Abstract: The application relates to substituted 4-phenylpiperidines of the general formula and their salts, preferably their pharmaceutically acceptable salts, in which R2, R3, W and X have the meanings explained in the description, a process for their preparation and the use of these compounds as medicines, especially as renin inhibitors.
Patent CA-2638292-A1 (CA)
Title: Enhanced production of taxanes by cell cultures of taxus species
Inventor: BRINGI VENKATARAMAN
IPC: C12N5/00
Filed: 1997-05-27
Abstract: Production of taxanes in high yields in cell culture of a Taxus species comprises: (a) cultivating in suspension, using >= 1 nutrient media (containing an inhibitor of phenylpropanoid metabolism), cells of a Taxus sp. derived from callus or suspension cultures, and (b) recovering >= 1 taxanes from the cells and/or the medium of the cell culture.
Patent CA-2639490-A1 (CA)
Title: Networked digital media review & play system
IPC: H04L12/58
Filed: 2008-09-09
Abstract: A system for the play of digital content in a public establishment includes an in-house digital content play system, a web accessible digital content server, a media center connected to the in-house digital content play system and in communication with the digital content server to receive digital content, and independent web enabled or text messaging enabled devices of users. These independent web enabled or text messaging enabled devices allow a user to access the digital content server and select digital content for play on the in-house digital content play system.
Patent CA-2642964-A1 (CA)
Title: Plants comprising increased expression of myb-tf having increased seed yield, and a method for making same
Inventor: FRANKARD VALERIE
IPC: C12N15/82
Filed: 2007-02-27
Abstract: The present invention relates generally to the field of molecular biology and concerns a method for increasing plant yield relative to control plants. More specifically, the present invention concerns a method for increasing plant yield comprising increasing expression in a plant of a nucleic acid sequence encoding a MYB (DNA-binding) domain transcription factor (MYB-TF) polypeptide. In a particular embodiment, the present invention concerns a method for increasing plant yield comprising preferentially increasing expression of a nucleic acid sequence encoding a MYB-TF polypeptide, in the endosperm of a plant seed. The present invention also concerns plants having increased expression of a nucleic acid sequence encoding a MYB-TF polypeptide, as well as plants having preferentially increased expression of a nucleic acid sequence encoding a MYB-TF polypeptide in the endosperm of seeds, which plants have increased yield relative to control plants. The invention also provides constructs useful in the methods of the invention.
Patent CA-2644124-A1 (CA)
Inventor: COX SHAUN D
IPC: G06Q10/00
Filed: 2007-01-24
Abstract: A method and system for increasing the computational and network efficiency of presence servers having collections of publications is provided. The presence system uses several techniques that enable a presence server to provide rich presence information without requiring expensive processing. First, the presence system accepts batches of publication updates in a single presence update request. Similarly, the presence system accepts batches of subscription requests. Next, the presence system supports new expiration types for publication update requests that eliminate the need for a publishing user to continually refresh presence information that has not changed. Finally, the presence system accepts access lists that contain membership groups rather than an individual list of users that are to have access to a particular presence collection.
Patent CA-2644302-A1 (CA)
Title: Cathodal materials for lithium cells
Inventor: CHEN TU
IPC: H01M4/58
Filed: 2008-11-20
Abstract: A cathodal material for lithium cells comprises a porous lithium oxide microparticle is provided. The porous lithium oxide microparticle comprises a plurality of porous lithium oxide nanoparticles formed with a first conducti ve layer therein, a pore defined by connecting the lithium oxide nanoparticles, a second conductive layer covering at least a surface of one of the lithium oxide nanoparticles contacting the first conductive layer and forming a three-dimensional conductive network between the lithium oxide nanoparticles, and a conductive fiber connecting with the second conductive layer.
Patent CA-2647302-A1 (CA)
Title: Causal analysis in complex biological systems
Inventor: POLLARD JACK JR
IPC: G16B5/00
Filed: 2007-03-20
Abstract: Disclosed are software assisted systems and methods for analyzing biological data sets to generate hypotheses potentially explanatory of the data. Active causative relationships in the biology of complex living systems are discovered by providing a data base of biological assertions comprising a multiplicity of nodes representative of a network of biological entities, actions, functional activities, and concepts, and relationship links between the nodes. Simulating perturbation of individual root nodes in the network initiates a cascade of virtual activity through the relationship links to discern plural branching paths within the data base. Operational data, e.g., experimental data, representative of a real or hypothetical perturbations of one or more nodes are mapped onto the data base. The branching paths then are prioritized as hypotheses on the basis of how well they predict the operational data. Logic based criteria are applied to the graphs to reject graphs as not likely representative of real biology.
Patent CA-2647921-A1 (CA)
Title: Method and system for configuring a contact database associated with a user
Inventor: ARSENAULT JONATHAN ALLAN
IPC: H04M3/42
Filed: 2008-12-24
Abstract: A method implemented by a network entity that comprises identifying contact information associated with a previously-originated call, receiving from a user information indicative of a desired modification to a database associated with the user, wherein the desired modification involves the contact information associated with the previously-originated call. The method further comprises configuring the database associated with the user at least in part on the basis of the desired modification and the contact information associated with the previously-originated call.
Patent CA-2648459-A1 (CA)
Inventor: DOMINY STEPHEN S
IPC: C12Q1/00
Filed: 2007-04-05
Abstract: The present invention relates to aberrant cell signaling by the HIV type I envelope glycoprotein. In particular, the present invention provides compositions and methods for identification of inhibitors of melanocortin receptor pathway stimulation by HIV-I gpl20 and its degradation products. The inhibitors so identified are contemplated to be suitable for treating HIV-related cachexia, T cell hyperactivation and central nervous system disease.
Patent CA-2649255-A1 (CA)
Title: Bi-directional light emitting diode drive circuit in pulsed power non-resonance
Inventor: YANG TAI-HER
IPC: H05B44/00
Filed: 2009-01-12
Abstract: The present invention uses capacitive, inductive, or resistive impedance to constitute the first impedance, and the capacitive and inductive impedances in parallel connection which will not produce parallel resonance to constituted the second impedance, and is characterized in that the first and second impedance in series connection is configured for inputting pulsed power, thereby to form a bi-directional power in decaying wave shape at the two ends of the second impedance to drive the bi-directional conducting light emitting diode.
Patent CA-2651412-A1 (CA)
Inventor: JUSTINEN BRUCE
IPC: A61F5/37
Filed: 2009-01-28
Abstract: An article of apparel adapted to provide a compressive pressure to reduce lymphedema, the pressure configured to direct edema in a direction, wherein the apparel may be a garment adapted to be worn on an upper body portion of a user and may include a body portion, arm portions, and a neck portion, the body portion including a front portion, a back portion, and chest wall portions, wherein, the front, back, and chest wall portions may be adapted to encircle the torso of a user and provide compressive pressure, the arm portions including sleeve portions and underarm portions wherein the sleeve and underarm portions may be adapted to encircle the arms of a user and provide compressive pressure. Using the article of apparel as or in a method of reducing lymphedema is encompassed.
Patent CA-2651888-A1 (CA)
Title: Carbon dioxide absorbent requiring less regeneration energy
Inventor: WAGNER RUPERT
IPC: C01B32/50
Filed: 2007-05-11
Abstract: Disclosed is an absorbent for eliminating carbon dioxide from a gas flow. Said absorbent comprises an aqueous solution of at least one amine and at least one amino carboxylic acid and/or amino sulfonic acid. Additionally using an amino carboxylic acid or amino sulfonic acid reduces the amount of energy required for regenerating the absorbent.
Patent CA-2654420-A1 (CA)
Inventor: KING TE PIAO
IPC: C07H21/04
Filed: 1994-03-10
Abstract: The present invention is directed to nucleic acids encoding vespid venom enzymes, or fragments thereof, recombinant vectors comprising such nucleic acids, and host cells containing the recombinant vectors. The invention is further directed to expression of such nucleic acids to produce recombinant vespid venom enzymes, or recombinant fragments, derivatives or analogs thereof. Such recombinant products are useful for diagnosis of allergy and for therapeutic treatment of allergy. In specific embodiments, the present invention provides nucleic acids encoding, and complete nucleotide and amino acids sequences for, vespid venom phospholipase, for example, Dolichovespula maculata phospholipase and Vespula vulgaris phospholipase, and vespid venom hyaluronidase, for example, Dolichovespula maculata hyaluronidase.
Patent CA-2656005-A1 (CA)
Title: Chemotherapeutic compounds for selectively targeting tumor cells with fr type receptors
Inventor: GANGJEE ALEEM
IPC: A61K31/535
Filed: 2007-06-26
Abstract: A compound for treating cancer tumors, particularly ovarian cancer tumors, is described, where a fused cyclic pyrimidine having a cancer treating ability is effective to allow selective delivery to a cancerous tumor.